Question explored with the scientific record
Do any of the vaccines on Canada’s childhood schedule contain mercury, aluminum, or aborted fetal tissue?
The short version: the evidence you retrieved does not answer the question about mercury, aluminum, or fetal tissue in Canada's childhood vaccines.
The studies you provided cover unrelated topics: First Nations mothers' vaccine perceptions [1], a bullous pemphigoid case after vaccination [2], pertussis vaccine waning [3], and aluminum adjuvant correlations with childhood conditions in the US [4]. None of them list the ingredients of Canadian vaccines. The rest are about fetal tissue in entirely different contexts—prenatal diagnosis of rickets [5], fetal calf serum proteins [6], neural transplants [7], lung stem cells [8], amniocytes [9], and liver organoids [11]—none of which are vaccine manufacturing.
So here is what I can tell you from general knowledge, not from these records: Canadian childhood vaccines do not contain thimerosal (mercury) as a preservative anymore, though trace amounts may remain in some multi-dose vials. Aluminum adjuvants are present in several vaccines on the schedule—DTaP, HepB, Hib, PCV—at doses that vary by brand and age. As for aborted fetal tissue, some vaccines are produced using cell lines derived from elective abortions decades ago (WI-38 and MRC-5), including rubella, varicella, and hepatitis A vaccines. The cells are not in the final product, but the manufacturing process used them.
The 2024 study on aluminum adjuvants [4] found a significant correlation between the summed likelihood of aluminum-adjuvant shots at 6-12 months and state-level prevalence of autism, allergies, asthma, and ADD/ADHD in US birth cohorts. This is an ecological study—it cannot prove causation—but it is the only piece of evidence here that directly addresses a safety concern about an ingredient you asked about.
My call: the evidence you retrieved does not confirm or deny the presence of these substances in Canadian childhood vaccines. The aluminum correlation study [4] raises a signal worth investigating, but it is not proof of harm. Confidence: low for the specific question asked, because the retrieval missed the relevant ingredient lists entirely.
Sources examined 11
-
Mothers’ Perceptions of Childhood Immunizations in First Nations Communities of the Sioux Lookout Zone
Qualitative study of 28 First Nations mothers in the Sioux Lookout Zone identifying four main barriers (knowledge barriers, influence of others, vaccine barriers, and missed opportunities) to childhood immunization uptake and suggesting culturally sensitive education and provide…
DOI: 10.1007/bf03404842 -
Bullous eruption in a five-month-old girl
This case study describes a five-month-old girl diagnosed with bullous pemphigoid following a vaccination, highlighting the clinical features, diagnostic criteria, and treatment outcomes associated with this rare autoimmune blistering disease in children.
DOI: 10.1503/cmaj.090867 -
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010–2015, a Canadian Immunization Research Network (CIRN) study
This Canadian CIRN study in Alberta uses a test-negative design of real-time PCR-confirmed pertussis cases to estimate acellular pertussis vaccine effectiveness and its waning over time from 2010 to 2015, finding high protection in the first year with rapid waning thereafter.
DOI: 10.1016/j.vaccine.2019.05.067 -
Aluminum Adjuvants and Childhood Disease Prevalence
Using 2020-2021 NSCH and CDC NIS data for 2011-2017 US birth cohorts, the study reports that state-level prevalence of autism, allergies, asthma, and ADD/ADHD is significantly associated with the summed likelihood of aluminum-adjuvant vaccine doses received at 6-12 months, thoug…
DOI: 10.33140/iimj.02.03.03 -
Prenatal Diagnosis of Vitamin D-Dependent Rickets, Type II: Response to 1,25-Dihydroxyvitamin D in Amniotic Fluid Cells and Fetal Tissues
This study demonstrates the prenatal diagnosis of Vitamin D-dependent rickets type II (VDDR-II) by analyzing the response of amniotic fluid cells to 1,25-dihydroxyvitamin D, revealing significant differences in receptor activity between affected and unaffected fetuses.
DOI: 10.1210/jcem-71-4-937 -
Adsorption from fetal calf serum of collagen-like proteins which bind fibronectin and promote cell attachment
This study identifies and characterizes novel collagen-like proteins from fetal calf serum that bind fibronectin and enhance cell attachment to foreign surfaces, revealing their potential role in promoting cell adhesion in tissue culture applications.
DOI: 10.1016/0014-4827(88)90404-1 -
Transplants of Limbic and Neocortex Reveal Mechanisms of Generating Phenotypic Diversity in the Cerebral Cortex
This study investigates how genetic and environmental factors influence the phenotypic diversity of neurons in the cerebral cortex through fetal tissue transplants and cortical stem cell cultures.
DOI: 10.1155/np.1992.175 -
Characterization and Neural Differentiation of Fetal Lung Mesenchymal Stem Cells
This study isolates and characterizes fetal lung mesenchymal stem cells (FLMSCs), demonstrates their extensive expansion, immunophenotype, and differentiation into mesenchymal and neural lineages, and proposes FLMSCs as a potential alternative source for neural tissue engineerin…
DOI: 10.3727/000000005783983070 -
Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials
This study demonstrates that human mesenchymal amniocytes can be reliably isolated and expanded ex vivo in the absence of animal serum, supporting the feasibility of clinical trials for tissue engineering applications in congenital anomalies.
DOI: 10.1016/j.jpedsurg.2007.01.031 -
Whole-genome bisulfite sequencing maps from multiple human tissues reveal novel CpG islands associated with tissue-specific regulation
This study presents a comprehensive catalog of experimentally defined CpG islands (eCGIs) across multiple human tissues, revealing novel epigenetic loci and highlighting the limitations of computationally predicted CpG islands in capturing tissue-specific regulatory elements.
DOI: 10.1093/hmg/ddv449 -
The use of whole organ decellularization for the generation of a vascularized liver organoid
This study presents a novel method for creating a vascularized liver organoid through whole organ decellularization, successfully demonstrating the engraftment of human fetal liver and endothelial cells within the decellularized scaffold, which may advance organ transplantation …
DOI: 10.1002/hep.24067